A conserved conformation-dependent mechanism for the TREK two-pore domain potassium channel inhibitors carvedilol and fluphenazine.

Reich J, Riegelhaupt PM, Tucker SJ, McClenaghan C

Open source

DOI
10.1016/j.molpha.2026.100155
Published
2026 Sep 12
Container
Molecular pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.molpha.2026.100155,
  title = {A conserved conformation-dependent mechanism for the TREK two-pore domain potassium channel inhibitors carvedilol and fluphenazine.},
  author = {Reich J and Riegelhaupt PM and Tucker SJ and McClenaghan C},
  year = {2026},
  journal = {Molecular pharmacology},
  doi = {10.1016/j.molpha.2026.100155},
  url = {https://doi.org/10.1016/j.molpha.2026.100155}
}

RIS

TY  - JOUR
TI  - A conserved conformation-dependent mechanism for the TREK two-pore domain potassium channel inhibitors carvedilol and fluphenazine.
AU  - Reich J
AU  - Riegelhaupt PM
AU  - Tucker SJ
AU  - McClenaghan C
PY  - 2026
JO  - Molecular pharmacology
DO  - 10.1016/j.molpha.2026.100155
UR  - https://doi.org/10.1016/j.molpha.2026.100155
ER  - 

APA

J, R., PM, R., SJ, T., & C, M. (2026). A conserved conformation-dependent mechanism for the TREK two-pore domain potassium channel inhibitors carvedilol and fluphenazine.. Molecular pharmacology. https://doi.org/10.1016/j.molpha.2026.100155

Source records